An economic analysis of sumatriptan for acute migraine
Ilerisch L
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Ilerisch L. An economic analysis of sumatriptan for acute migraine. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA). 1997
Authors' objectives
To evaluate the cost and efficacy of sumitriptan from both the societal and Ministry of Health perspectives using models for cost-effectiveness, cost-utility, and cost benefit analyses.